Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Atlas Volumetric Dosing System

Product Description


The Atlas Syringe Pump is a versatile volumetric dosing and/or sampling system. It allows 2 independent refilling flows, one continuous flow, reaction sampling, intelligent control of pH and temperature dependant dosing. It consists of two syringes and multi port valves and can be controlled from the front panel, by the Reactor Master, an Atlas Base or PC software.

Atlas from Syrris is a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Designed specifically for ease of use, all Atlas chemical reactors can be scaled in 3 ways: by volume, automation level, and number of reactions.

What’s more, it’s extremely fast and easy to change configuration from one to another without tools. All of the systems are highly chemically resistant and automated synthesis can be controlled by the hardware or PC software.

Features & Benefits

Flexible: Use as 2 refilling pump channels or 1 continuous pump channel or an autosampler.

Easy to use on its own: Twist and click control knob and large display.

Automated reagent addition: Dispense simply by volume or flow rate over a time period or create advanced flow profiles.

Versatile: 10 reagents to one reactor, 1 reagent to 10 reactors, 5 reagents to 2 reactors, one continuous flow, etc.

Automated reaction sampling: Use with the Autosampler module to regularly aspirate samples into 2ml HPLC vials.

Wide flow rate range: 0.5 l/min to 10ml/min (up to 100ml/min with the Atlas Syringe Pump XL)

Intelligent: Pump to control pH or pause if a reaction temperature is exceeded. Full data logging to a csv file.

Compact size: Fits conveniently alongside reactor. Excellent chemical compatibility: PTFE, PCTFE and glass.

Product Atlas Volumetric Dosing System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos